Omalizumab for treatment of ABPA exacerbations in CF patients
- PMID: 19382216
- DOI: 10.1002/ppul.21002
Omalizumab for treatment of ABPA exacerbations in CF patients
Erratum in
- Pediatr Pulmonol. 2009 Sep;44(9):943-4
Comment on
-
Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab).Pediatr Pulmonol. 2008 Dec;43(12):1249-51. doi: 10.1002/ppul.20907. Pediatr Pulmonol. 2008. PMID: 19009619
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
